Platelet-derived serotonin links vascular disease and tissue fibrosis
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Vascular damage and platelet activation are associated with tissue remodeling in diseases such as systemic sclerosis, but the molecular mechanisms underlying this association have not been identified. In this study, we show that serotonin (5-hydroxytryptamine [5-HT]) stored in platelets strongly induces extracellular matrix synthesis in interstitial fibroblasts via activation of 5-HT2B receptors (5-HT2B) in a transforming growth factor β (TGF-β)–dependent manner. Dermal fibrosis was reduced in 5-HT2B−/− mice using both inducible and genetic models of fibrosis. Pharmacologic inactivation of 5-HT2B also effectively prevented the onset of experimental fibrosis and ameliorated established fibrosis. Moreover, inhibition of platelet activation prevented fibrosis in different models of skin fibrosis. Consistently, mice deficient for TPH1, the rate-limiting enzyme for 5-HT production outside the central nervous system, showed reduced experimental skin fibrosis. These findings suggest that 5-HT/5-HT2B signaling links vascular damage and platelet activation to tissue remodeling and identify 5-HT2B as a novel therapeutic target to treat fibrotic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3. 5-HT2B is overexpressed in patients with SSc. (A) 5-HT2B was detectable by immunohistochemistry in fibroblasts, keratinocytes, and microvessels of SSc patients and controls. Two representative tissue sections and an isotype control are shown. (B) 5-HT2B expression in SM22-α–negative and α-SMA–positive myofibroblasts. A representative skin section of an SSc patient is shown. SM22-α as specific marker for vascular smooth muscle cells was stained with DAB, the myofibroblast marker α-SMA with Alexa Flour 594 (red), and 5-HT2B with Alexa Flour 488 (green; n = 8 each). The stainings were performed in three independent series. Bars: (A and B [top]) 50 µm; (B, bottom) 10 µm.](https://figures.cochat.ai/paper-figures/2d4bce77e10e467e91ca2a569232e136/platelet-derived-serotonin-links-vascular-disease-and-tissue-fibrosis-figure-3.jpg)





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Importantly, mice that lack this receptor (5H-T2b-/-) are protected against bleomycin-induced skin fibrosis, just as mice in which the 5H-T2b, receptor is pharmacologically inhibited (149).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [149]
In the citing paper
“This effect runs via the 5H-T2b receptor; inhibition of this receptor with terguride decreases collagen and fibronectin production by fibroblasts.”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [149]
In the citing paper
“More recently, it was demonstrated that serotonin directly increases extracellular matrix production in primary skin fibroblasts (149).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [149]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Woessner, J. F. (1961) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(61)90291-0 · Cited by 3,840 · cited 1×
“To detect also highly cross-linked collagen, the collagen content in skin samples was analyzed by determination of the hydroxyproline content ( Woessner, 1961 ).”
Andrews, N. C., & Faller, D. V. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.9.2499 · Cited by 2,312 · cited 1×
“Nuclear and cytoplasmic extracts were prepared as previously described ( Andrews and Faller, 1991 ; Khelifi et al., 2005 ).”
Synthesis of Serotonin by a Second Tryptophan Hydroxylase Isoform
Walther, D. J., Peter, J.-U., Bashammakh, S., Hörtnagl, H., Voits, M., Fink, H., & Bader, M. (2003) · Science · doi:10.1126/science.1078197 · Cited by 1,570 · cited 4×
“TPH1 # / # mice and 5-HT2B # / # mice have been described previously ( Nebigil et al., 2000 ; Walther et al., 2003b ).”
InfluentialChanges in causes of death in systemic sclerosis, 1972–2002
Steen, V. D., & Medsger, T. A. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.066068 · Cited by 1,528
Bataller, R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524282c1 · Cited by 1,472 · cited 1×
“…fibrotic diseases such as systemic sclerosis (SSc) and organ-specific fibrosis such as kidney fibrosis, idiopathic pulmonary fibrosis, and liver cirrhosis share common pathophysiological mechanisms (Bataller and Brenner, 2005; Varga and Abraham, 2007; Strieter and Mehrad, 2009).”
Criteria for the classification of early systemic sclerosis.
LeRoy, E. C., & Medsger, T. A. (2001) · PubMed · Cited by 1,384
Gabrielli, A., Avvedimento, E. V., & Krieg, T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0806188 · Cited by 1,384
Systemic sclerosis: a prototypic multisystem fibrotic disorder
Varga, J., & Abraham, D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31139 · Cited by 1,163
Rothman, R. B., Baumann, M. H., Savage, J. E., Rauser, L., McBride, A., Hufeisen, S. J., & Roth, B. L. (2000) · Circulation · doi:10.1161/01.cir.102.23.2836 · Cited by 722
Research works printed but not linked: 1
- von Werner, 1989, Therapy with terguride, Nichidoku-Iho., 33, 189
Cited by
Items 201–300 of 302
New renal drug development to face chronic renal disease
Moll, S., Meier, M., Formentini, I., Pomposiello, S. I., & Prunotto, M. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.956075 · Cited by 7
“Thus, using both inducible and genetic experimental models of scleroderma, antagonism of the 5HT2B or its genetic deletion was recently shown to reduce dermal fibrosis [64].”
BackgroundPathogenesis of Pulmonary Arterial Hypertension
Tuder, R. M., Ponticos, M., & Holmes, A. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-31407-5_26 · Cited by 7
Pauling, J. D. (2014) · The University of Bath Online Publications Store (The University of Bath) · Cited by 7
A GPVI-platelet-neutrophil-NET axis drives systemic sclerosisPreprint
Darbousset, R., Villanueva-Martín, G., Kuehn, J., Navarro, S., Balu, S., Miglani, D., Dillon, E., Fromson, C., Senkpeil, L., Elahee, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.21.634123 · Cited by 7
Chaturvedi, S., Singh, H., Agarwal, V., Jaiswal, A. K., & Prasad, N. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1279330 · Cited by 6
Wollin, L., Trinh‐Minh, T., Zhang, Y., & Distler, J. H. W. (2021) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/g5mej7 · Cited by 6
“42q, National Institutes of Health, USA) as reported in previous studies (18-22).”
MethodSelf-citationSteiner, C. A., & Higgins, P. (2018) · Springer eBooks · doi:10.1007/978-3-319-90578-5_23 · Cited by 6
Gocht, A., Distler, J. H. W., Spriewald, B. M., Ramsperger-Gleixner, M., Weyand, M., Ensminger, S. M., & Heim, C. (2018) · Transplant Immunology · doi:10.1016/j.trim.2018.04.002 · Cited by 6
Self-citationHaam, S., Kukreja, A., Kang, B., Lee, T., Lim, E., Choi, Y., Suh, J., & Huh, Y. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s55525 · Cited by 6
Trinh‐Minh, T., Manh, C. T., Györfi, A., Dickel, N., Liebel, C., Zhou, X., Wang, J., Kunz, M., Arozenius, H., Pettersson, L., et al. (2025) · Arthritis & Rheumatology · doi:10.1002/art.43151 · Cited by 5
“Moreover, we demonstrate therapeutic effects of AM1476 in PCS slices from patients with SSc. PCS slices offer potential to evaluate therapeutic effects of drug candidates in an ex vivo trial approach, with evaluation of drug candidates directly in patient-derived target tissues with all relevant cellular players and p…”
InfluentialSelf-citationThe Immunopathophysiology of Organ Fibrosis: from Mechanisms to Immunotherapies
He, J., Ferapontova, I., Chen, J., Ito, M., Isagawa, T., Takeda, N., & Stockmann, C. (2025) · Physiology · doi:10.1152/physiol.00063.2024 · Cited by 6
Zhu, M., Xu, F., Zhu, L., Chen, Q., Jiang, X., Pan, C., Yu, W., & Zhang, H. (2025) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001735 · Cited by 5
HMGB1–Platelet Interactions: Mechanisms and Targeted Therapy Strategies
Fang, X., Zhou, X., Zhou, X., Cheng, Z., & Hu, Y. (2025) · Thrombosis and Haemostasis · doi:10.1055/a-2622-0074 · Cited by 5
Fallet, B., & Walker, U. A. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1832466 · Cited by 5
Asano, Y., & Distler, J. H. W. (2016) · Springer eBooks · doi:10.1007/978-3-319-31407-5_19 · Cited by 5
Self-citationThe pathogenesis of idiopathic pulmonary fibrosis
Fahim, A. (2011) · Repository@Hull (Worktribe) (University of Hull) · Cited by 5
Li, D., Li, M., Gao, H., Hu, K., Xie, R., Fan, J., Huang, M., Liao, C., Han, C. W., Guo, Z., et al. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1475984 · Cited by 4
5-HT2B Receptor on Macrophages: What for?
Nieto, C., Rayo, I., & Corbí, A. L. (2021) · The Receptors · doi:10.1007/978-3-030-55920-5_6 · Cited by 4
Takeda, A., Fujita, M., & Funakoshi, K. (2023) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2023.102281 · Cited by 4
Chaturvedi, S., Rai, M. K., Singh, H., Misra, D. P., Prasad, N., Agrawal, V., & Agarwal, V. (2020) · Indian Journal of Rheumatology · doi:10.4103/injr.injr_169_19 · Cited by 4
“[5] TGF-β1 is the main pro-fibrotic factor that leads to fibrosis of the skin.”
Systemic sclerosis and its cerebral, neurological, and psychiatric impacts: a narrative review
da Silva, R. C. T., Arruda, J. D. M., Pereira, M. C., Rêgo, M. J. B. D. M., Pitta, M. G. D. R., & da Rosa, M. M. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149779 · Cited by 3
Anxiety and Depression in Inflammatory Rheumatic Diseases
Dušanka, M. P., Kaliterna, M., Nuic, D. P. M., & iÃÂ, I. B. Â. ⁄. (2015) · Rheumatology Current Research · doi:10.4172/2161-1149.1000166 · Cited by 3
“For example, newer studies found relationships between serotonin and skin fibrosis [48,49].”
BackgroundPande, G., Sharma, S., Rai, M., Misra, D. P., Gupta, L., & Agarwal, V. (2020) · Indian Journal of Rheumatology · doi:10.4103/injr.injr_159_20 · Cited by 3
Bhat, L., Bhat, S. R., Nault, M.-C., Biernat, M., & Labbe, S. (2023) · Medical Research Archives · doi:10.18103/mra.v11i4.3837 · Cited by 3
Maroteaux, L., Roumier, A., Doly, S., Diaz, S. L., & Belmer, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_286 · Cited by 3
Self-citationDNA methylation aberrancy is a reliable prognostic tool in uveal melanomaPreprint
Šoltýsová, A., Dvorská, D., Kajabová, V. H., Pecimonova, M., Cepcekova, K., Ficek, A., Demková, L., Buociková, V., Babál, P., Juras, I., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2502537/v2 · Cited by 3
Zhou, X., Li, J.-J., Li, S., Liu, H., & Chi, C. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.145704 · Cited by 2
Li, X., Zhang, F., Shen, A., Hu, J., Chen, M. Z., & Yang, H. (2023) · Natural Product Communications · doi:10.1177/1934578x231214947 · Cited by 2
“51 In contrast, treatment of human lung fi broblasts with inhibitors of the 5-HT transporter 5-HT2A/2B inhibited TGF-β expression and reduced collagen deposition.”
BackgroundDao, M. Q., Vangal, P., Montalmant, K. E., Meléndez, C., Yu, B., Chowdhury, S., Won, P., Ayadi, A. E., Yao, A. S., Taub, P. J., et al. (2025) · Journal of Burn Care & Research · doi:10.1093/jbcr/iraf196 · Cited by 2
Advances in Management of Pulmonary Hypertension Associated with Systemic Sclerosis
Swisher, J. W., & Kailash, S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.86217 · Cited by 2
Levy, R. J., Fitzpatrick, E., Castillero, E., Shukla, H. J., Inamdar, V. V., Aghali, A., Grau, J. B., Rioux, N., Salvati, E., Keeney, S. J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.10.985382 · Cited by 2
Distler, O., Neidhart, M., & Błyszczuk, P. (2021) · The Receptors · doi:10.1007/978-3-030-55920-5_13 · Cited by 1
Self-citationPlatelet-serotonin dynamics: elucidating their role in pulmonary arterial hypertension
Mindubayeva, F., Ospanova, M., Akhmaltdinova, L., & Толеубаевна, Т. Б. (2024) · Journal of Clinical Medicine of Kazakhstan · doi:10.23950/jcmk/14684 · Cited by 1
The multifaceted role of platelets in systemic sclerosis: beyond haemostasis!
Batani, V., Güler, A. A., & Colic, J. (2026) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000917 · Cited by 1
A molecular link between vascular disease, platelet activation and tissue fibrosis in SSc
Buckland, J. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.72 · Cited by 1
Investigative Approaches to Drug Therapy
Ong, V. H., & Denton, C. P. (2011) · Springer eBooks · doi:10.1007/978-1-4419-5774-0_50 · Cited by 1
Phenotype of Mice Lacking Tryptophan Hydroxylase 1
Bäder, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-800050-2.00009-7 · Cited by 1
An in vivo and in ovo evaluation of the toxicity of Sibutramine
van der Schoor, C. (2014) · UpSpace Institutional Repository (University of Pretoria) · Cited by 1
The Role of Serotonin in Atherosclerosis
Seibel, Y. (2020) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/21818 · Cited by 1
“The same is true for 5-HT2B -/- which are lacking the 5-HT2B receptor (Dees et al., 2011) (see also Tab.”
5-Hydroxytryptamine Receptor 2B
Doly, S., Diaz, S. L., Belmer, A., Roumier, A., & Maroteaux, L. (2012) · Springer eBooks · doi:10.1007/978-1-4419-0461-4_286 · Cited by 1
Self-citationTyp-2 innate Lymphozyten als neuer Zelltyp in der Fibrose
Weber, S. (2023) · OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg) · Cited by 1
Dogan, V. (2016) · OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg) · Cited by 1
Blood Platelets and Systemic Sclerosis
Lepreux, S., Solanilla, A., Villeneuve, J., Constans, J., Desmoulière, A., & Ripoche, J. (2012) · InTech eBooks · doi:10.5772/25866
Untersuchung der fibrotischen Effekte des Dopaminagonisten Cabergolin an Herzklappen des Schweins
Kekewska, A. (2013) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-4801
Use of Platelet-Rich Plasma for Collagen Matrixes Revitalization with Human Fibroblast
Makarov, M. S., Боровкова, Н. В., Konushko, O. I., & Хватов, В. Б. (2015) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2015.310011
“81 way is to use fluids with platelet components—blood serum, fibrinolytic active plasma, platelet-rich plasma [7] [8] [10] [13]—due to unique biological properties of platelets, containing the vast amount of growth and other factors, commonly involved in many processes of reparation and regeneration [9].”
BackgroundMethodPolarización de macrófagos: efecto de las inmunoglobulinas y de la serotonina
Engel, M. D. L. C. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Mechanismen der Fibrose und ihre Translation in die Klinik
Beyer, C., & Distler, J. H. W. (2014) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-013-1334-3
Self-citationPulmonary arterial hypertension in connective tissue
Hassoun, M., Maurer, B., Distler, O., & Hassoun, P. M. (2012)
Self-citation黄, 建. (2013) · Hans Journal of Medical Cosmetology · doi:10.12677/hjmc.2013.11001
Thérapie ciblée anti-OX40 Ligand dans des modèles murins de Sclérodermie systémique
Elhaï, M. (2015) · theses.fr (ABES) · doi:10.70675/43e178dbzd310z46dczb297z9d026198fb4b
“L’invalidation génétique de 5-HT2B prévient la fibrose dermique dans les modèles murins de fibrose induite par la bléomycine et dans le modèle tsk-1(185).”
BackgroundNieto, C., Rayo, I., Casas-Engel, M. D. L., Izquierdo, E., Alonso, B., Vega, M. A., & Corbí, A. L. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/587709
Neuroendokrine paraneoplastische Syndrome
Böhm, M., & Gellner, R. (2021) · Der Hautarzt · doi:10.1007/s00105-021-04778-5
Huang, J. (2016) · OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg)
Böhm, M. (2021) · Experimental Dermatology · doi:10.1111/exd.14403
Hernandez, I. R. (2020) · Docta Complutense (Universidad Complutense de Madrid)
Investigative Approaches to Drug Therapy
Ong, V. H., & Denton, C. P. (2016) · Springer eBooks · doi:10.1007/978-3-319-31407-5_42
Faculty Opinions recommendation of PU.1 controls fibroblast polarization and tissue fibrosis.
Nanchahal, J. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734947940.793569335
Maroteaux, L., Roumier, A., Doly, S., Diaz, S. L., & Belmer, A. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_286-1
Self-citationAberrant DNA methylation of uveal melanoma drivers as an excellent prognostic toolPreprint
Šoltýsová, A., Dvorská, D., Kajabová, V. H., Pecimonova, M., Cepcekova, K., Ficek, A., Demková, L., Buociková, V., Babál, P., Juras, I., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2502537/v1
Pathogenesis of Pulmonary Arterial Hypertension
Ponticos, M., Lee, M. H., Holmes, A. M., & Tuder, R. M. (2024) · Springer eBooks · doi:10.1007/978-3-031-40658-4_27
Asano, Y., & Distler, J. H. W. (2024) · Springer eBooks · doi:10.1007/978-3-031-40658-4_19
Self-citationMechanisms of Vascular Disease
Manetti, M., & Kahaleh, B. (2024) · Springer eBooks · doi:10.1007/978-3-031-40658-4_16
The Platelet-Specific Gene Signature in the Immunoglobulin G4-Related Disease Transcriptome
Oğuz, A. K., Oygür, Ç. Ş., Dedeoğlu, B. G., Doğan, İ., Kilicoglu, S. S., & Ergün, İ. (2025) · Medicina · doi:10.3390/medicina61010162
Zeng, Y., Zeng, W., Li, Z., Yang, X., Pan, J., & Ling, L. (2025) · medRxiv · doi:10.1101/2025.04.02.25325153
Platelets in Inflammatory Connective Tissue Disorders
Petito, E. (2025) · Springer eBooks · doi:10.1007/978-3-031-96352-0_20
Emerging Perspectives in Anti-aging Treatments Using Anti-Fibrotic Strategies
Wang, Y., Xi, C., Yang, J., Wang, M., Zeng, L., Zhang, L. L., & Gao, C. H. (2025) · Aging and Disease · doi:10.14336/ad.2025.1204
ROS/RNS modulation in Systemic sclerosis treatment
Marut, W. (2012) · theses.fr (ABES) · doi:10.70675/1a3042a6zb55az4a7fzb7afz8314dc4b8c3b
Kondo, M., Suzuki, T., Kawano, Y., Kojima, S., Miyashiro, M., Matsumoto, A., Kania, G., Błyszczuk, P., Ross, R. L., Mulipa, P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20787110
Self-citationKondo, M., Suzuki, T., Kawano, Y., Kojima, S., Miyashiro, M., Matsumoto, A., Kania, G., Błyszczuk, P., Ross, R. L., Mulipa, P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20787116
Self-citationKondo, M., Suzuki, T., Kawano, Y., Kojima, S., Miyashiro, M., Matsumoto, A., Kania, G., Błyszczuk, P., Ross, R. L., Mulipa, P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20787122
Self-citationKondo, M., Suzuki, T., Kawano, Y., Kojima, S., Miyashiro, M., Matsumoto, A., Kania, G., Błyszczuk, P., Ross, R. L., Mulipa, P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20787113
Self-citationKondo, M., Suzuki, T., Kawano, Y., Kojima, S., Miyashiro, M., Matsumoto, A., Kania, G., Błyszczuk, P., Ross, R. L., Mulipa, P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20787125
Self-citationEvaluation neuer molekularer Ansätze für die Behandlung der Fibrose
Zerr, P. (2013) · OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg)
Self-citationJahn, U. (2023) · Uppsala University Publications (Uppsala University)
Vitamin D-Rezeptor als Regulator des TGF-ß-Signalwegs bei systemischer Sklerose
Vollath, S. (2013) · OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg)
Biomarcadores intraplaquetarios y de crecimiento en esclerosis sistémica
Flores-Robles, B. J. (2021) · Hispana
Evaluation of novel molecular targets for the treatment of systemic sclerosis
Dees, C. (2012) · OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg)
Self-citationThérapies cellulaires appliquées à la sclérodermie systémique : état des lieux & perspectives
Velier, M. (2019) · HAL AMU
Papadimitriou, T. (2025) · Radboud University Press eBooks · doi:10.54195/9789465151144
Activation fibroblastique et nouvelles approches thérapeutiques dans la Sclérodermie systémique
Kavian, N. (2012) · theses.fr (ABES) · doi:10.70675/88a7811ez00a9z46eazb8fczef665f93a69f
Ayme‐Dietrich, E. (2016) · theses.fr (ABES) · doi:10.70675/1793300fzef15z4301zbbe9z635150305acb
Magalon, J. (2018) · theses.fr (ABES) · doi:10.70675/917579acze581z4bfbzb10czc6d5c3150e9d
Etude des mécanismes fibro-inflammatoires au cours de la sclérodermie systémique
Morin, F. (2016) · theses.fr (ABES) · doi:10.70675/9866eab9zdf94z44caz805az9242db5026c4
Etude des interactions entre les lymphocytes B et la peau dans la sclérodermie systémique
Maître, M. L. (2024) · theses.fr (ABES) · doi:10.70675/4b83f7f1zd61cz4394za897zc4d5039d086f
Ronda, A., Płatek, R., Słonimska, P., Kozłowska-Tylingo, K., & Sachadyn, P. (2026) · Scientific Reports · doi:10.1038/s41598-026-53380-z
“There is substantial data connecting increased 5-HT levels with tissue fibrosis 64 , as observed in cardiac valves, lungs, and skin in subjects with carcinoid neuroendocrine tumours that secrete vast quantities of 5-HT. Similarly, persistent 5-HT signalling disrupts healing processes during chronic…”
Wu, C., Wang, X., Shen, X., Liu, D., Huang, S., Wang, W., Peng, L., & Yin, W. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12509-z
“By using TGF-β1 and 5-HT co-stimulation to mimic a pro-fibrotic microenvironment [25 , 26 ], we observed that EG effectively suppressed 5-HT2B-associated signaling, yielding effects parallel to those of a pharmacological antagonist.”
BindingDB Entry 50049088: Optimization of spirocyclic proline tryptophan hydroxylase-1 inhibitors.
BindingDB (2019) · UC San Diego · doi:10.7270/q21v5h7s
Metadata
- Authors
- Dees, C., Akhmetshina, A., Zerr, P., Reich, N., Palumbo, K., Horn, A., Jüngel, A., Beyer, C., Krönke, G., Zwerina, J., Reiter, R., Alenina, N., Maroteaux, L., Gay, S., Schett, G., Distler, O., & Distler, J. H. W.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University Hospital Zurich (CH)
- ErgoNex Pharma GmbH, CH-9050 Appenzell, Switzerland 3
- Max Delbrück Center (DE)
- Inserm (FR)
- Corresponding author
- Distler, Jörg H.W.
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2011-04-25
- Volume
- 208
- Issue
- 5
- Pages
- 961-972
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC3092343
- OpenAlex
- W2025287936
- Cited by
- 266
- References
- 63
- Citations by year
- 2026: 3 · 2025: 14 · 2024: 11 · 2023: 11 · 2022: 13 · 2021: 22 · 2020: 22 · 2019: 14 · 2018: 22 · 2017: 12 · 2016: 20 · 2015: 16 · 2014: 21 · 2013: 21 · 2012: 37
- FWCI
- 19.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- serotonin, platelets, 5-HT2B receptor, skin fibrosis, systemic sclerosis, extracellular matrix synthesis, fibroblasts, TGF-beta signaling, platelet activation, vascular injury, tissue remodeling, tryptophan hydroxylase 1, therapeutic target
- MeSH terms
- Animals, Blood Platelets, Disease Models, Animal, Extracellular Matrix, Fibroblasts, Fibrosis, Humans, Scleroderma, Systemic, Serotonin, Signal Transduction, Platelet Activation, Transforming Growth Factor beta, Mice, Knockout, Receptor, Serotonin, 5-HT2B, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.